$TBIO I guess TBIO mgmt may not have agreed to sell off to $SNY For Sanofi, it makes sense to keep everyone at TBIO friendly, else no point doing a hostile take-over on a knowledge based company. $SNY may have been scared of a poison pill, eg:- if key scientists and researchers quit and start a new company, then what will Sanofi have bought? I believe SNY is paying money to keep TBIO management and employees happy and working hard on innovative m-RNA solutions as that is where the future lies. $MRNA and $BNTX have already proven that MRNA tech works, so makes sense that SNY is pumping in billions to have their own little messenger-RNA start-up in TBIO. It may take an year or two, but TBIO will hit $100 PT
  • 5
5 Likes